スポンサーリンク
Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences | 論文
- Clinical Usefulness of Oral Combination Chemotherapy of 5'-Deoxy-5-Fluorouridine (5'-DFUR) and Cyclophosphamide for Metastatic Breast Cancer
- Immunohistochemical Analysis on Biological Markers in Ductal Carcinoma in situ of the Breast
- Comparison of Five Different Antibodies in the Immunohistochmical Assay of Estrogen Receptor α in Human Breast Cancer
- Expression of Estrogen Receptor α Exon 5 and 7 Deletion Variant in Human Breast Cancers
- Consecutively Occurring Multiple Fibroadenomas of the Breast Distinguished from Phyllodes Tumors by Clonality Analysis of Stromal Tissue
- The Clinical Value of Microsatellite Instability and a Loss in Heterozygosity in Sporadic Breast Cancers
- Ratio of Expression of p16^ to p14^ Correlates with the Progression of Non-small Cell Lung Cancer
- Telomerase Activity Levels for Evaluating the Surgical Margin in Breast-Conserving Surgery
- Localization of Gelatinolytic Activity Can Be Detected in Breast Cancer Tissues by Film in situ Zymography
- Readministration of Tamoxifen After Adjuvant Therapy for Recurrent Breast Cancer
- Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer
- Flow Cytometric Assay of C-erb B-2 Protein in Fine Needle Aspirates of Fresh and Frozen Human Breast Cancer Tissues
- Metachronous Primary Hyperparathyroidism Due to a Parathyroid Adenoma and a Subsequent Carcinoma : Report of a Case
- Estrogen Receptor α Mutation (A-to-G Transition at Nucleotide 908) Is Not Found in Different Types of Breast Lesions from Japanese Women)
- Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment
- Clinical Significance of Estrogen Receptor β in Breast Cancer
- A Case of Invasive Micropapillary Carcinoma of the Breast
- A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment
- Current research topics in endocrine therapy for breast cancer
- Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer